ASAnkit Sarin

Ankit Sarin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ankit Sarin has a total of 114 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Implementation of a single-port robotic platform into your colorectal surgery practice: a SAGES colorectal committee task force review of evolving robotic technology and innovations

    by Ankit Sarin, Justin Dourado, Christopher M. Seffren, Upinder S. Sidhu, Poya Pourghaderi, Nathan Aminpour, Elisabeth C. McLemore, Giovanni Dapri, Nawar A. Alkhamesi, Sherief Shawki, et al.

    Background: Robotic and endoscopic techniques continue to revolutionize minimally invasive surgery. Single-port (SP) robotic platforms mark a new era in minimally invasive colorectal surgery, combining single-incision/site access with full robotic articulation through a single access point. This manuscript, as a part of a four-part series, outlines specific technical considerations of the SP robotic platform including details of the platform, instrumentation, docking, and operative maneuvers. Methods: Subject matter experts from the SAGES Colorectal Committee SP Task Force performed a structured review of the currently FDA-approved SP robotic platform, assessing technical features, instrumentation, and workflow considerations for several key representative operations relevant to colorectal surgery. Three clinical areas of SP implementation included transanal robotic surgery, right colectomy, and low anterior resection (LAR). Task Force members (subject matter experts with early experience in SP robotic platforms) analyzed technical details, patient selection, and operative workflows. Representative procedural techniques were detailed with emphasis on instrumentation choice, docking strategies, and key operative steps specific to single-port colorectal surgery. Results: The technical aspects of the SP platform include full robotic articulation through a single 25 mm port. A SP approach also enables triangulation and dexterity within confined spaces using three wristed instruments and a flexible 3-D camera. The current 360-degree boom rotation facilitates multi-quadrant manipulation without redocking. Current limitations may include continued reliance on bedside assistance for certain energy and stapling operative steps, although stapling capability has expanded with FDA clearance of an SP-compatible 45 mm stapler as of April 2025. Training of the entire operative team and gradual progression of case complexity is recommended as the surgeon implements this new technology into clinical practice. Conclusions: A SP robotic approach to minimally invasive colorectal surgical procedures is feasible for a range of colorectal surgery operations. In select procedures like SP TAMIS, SP right colectomy, and SP-LAR, the single-port platform appears to offer advantages related to reduced invasiveness and improved surgeon ergonomics compared to other minimally invasive approaches. Successful implementation requires structured training, careful patient selection, and adherence to evidence-based adoption principles.

  • Artificial Intelligence for Colorectal Surgeons—Part I: Foundations and Clinical and Educational Applications

    by Ankit Sarin, Christopher M Seffren, Hussam A. Shwaib, Monique Couto Matos, Samuel Eisenstein, Marco Ferrara, Nell Maloney Patel, Sean J. Langenfeld

    BACKGROUND: Artificial intelligence is rapidly transforming colorectal surgery through applications spanning screening to postoperative care. This 2-part review provides a comprehensive framework for understanding and implementing artificial intelligence technologies in surgical practice. OBJECTIVE: Part I analyzes fundamental artificial intelligence concepts, clinical applications across the surgical continuum, and educational considerations for colorectal surgeons. METHODS: Comprehensive literature review focusing on artificial intelligence applications in colorectal surgery, evaluating current evidence for clinical implementation and training approaches. RESULTS: Artificial intelligence demonstrates measurable clinical impact across multiple domains. In screening, artificial intelligence–enhanced colonoscopy increases adenoma detection rates from 40.4% to 54.8% ( p < 0.001) in multicenter trials, with cross-validation on colonoscopy images demonstrating 96.4% polyp detection accuracy. Diagnostic applications include microsatellite instability prediction from histology and automated MRI tumor segmentation. Preoperatively, machine learning models predict mortality and morbidity, outperforming traditional risk measures such as the American Society of Anesthesiologists classification and the American College of Surgeon-National Surgical Quality Improvement Program. Intraoperatively, artificial intelligence has demonstrated early feasibility for real-time tissue plane, artificial intelligence–based automated perfusion assessment can predict anastomotic viability, and artificial intelligence can enable identification of critical structures such as pelvic nerves. Postoperatively, artificial intelligence is starting to detect complications hours before clinical diagnosis, reducing documentation time. Educational applications include artificial intelligence–enhanced simulation platforms, objective video-based performance assessment, and integration with virtual/augmented reality for immersive training experiences. CONCLUSIONS: Artificial intelligence technologies have achieved clinical validation for specific colorectal surgery applications, with several technologies receiving regulatory approval. Successful integration requires understanding fundamental concepts, appropriate clinical application, and structured training approaches. Part II of this series analyzes research applications, implementation resources, challenges, and future directions that will further transform surgical practice.


  • Open Access

    White paper on effective preacquisition evaluation of soft tissue robotic surgery platforms for healthcare institutions

    by Ankit Sarin, Dimitrios Stefanidis, Jay A. Redan, Paresh C. Shah, Patricia Sylla

    Background: With the increasing popularity of robotic surgery among surgeons, the selection of soft tissue robotic surgery platforms represents a critical strategic decision for healthcare institutions. Following patent expirations in robotic technology, institutions face increasingly complex choices among diverse platforms with varying capabilities, costs, and implementation requirements. The goal of this white paper was to define a framework for evaluating robotic surgical platforms to aid acquisition decisions by healthcare institutions. Methods: Based on expert robotic surgeon opinion informed by the IDEAL Framework (Idea, Development, Exploration, Assessment, and Long-term study) and Multi-Criteria Decision Analysis (MCDA) methodology, and discussions with industry stakeholders, core decision domains for the acquisition of a robotic system were defined and a comprehensive framework for evaluating robotic surgical platforms was developed. The impact of procedure, specialty, and institution-specific variations of the selection criteria was explored. Results: Eight core decision domains were identified: clinical outcomes and patient relevance, hospital-specific considerations, technology-specific attributes, physician needs and preferences, surgeon and trainee education, economic implications, policy and regulatory factors, and long-term sustainability. According to this framework, financial sustainability timelines vary substantially based on case mix, payer composition, and implementation approach, with specialty-focused programs typically achieving positive returns more rapidly than broad multi-specialty implementations. Economic models illustrate different return-on-investment scenarios for academic medical centers, community hospitals, and specialty surgical centers. Educational infrastructure significantly impacts long-term program success, with platforms offering comprehensive simulation, dual-console training, and proficiency-based progression frameworks promoting enhanced adoption and utilization rates. Conclusion: The proposed framework provides institutions with a systematic approach to robotic platform selection designed to maximize clinical outcomes, operational efficiency, educational effectiveness, and financial sustainability, while avoiding common implementation pitfalls that have historically undermined robotic program success.


  • Developing an Academic Colorectal Division

    by Ankit Sarin, Alessandro Fichera, Jennifer S. Davids, Virginia O. Shaffer, Skandan Shanmugan, Justin A. Maykel, Patricia Sylla

  • Top Cited Papers
    Open Access

    Upcoming multi-visceral robotic surgery systems: a SAGES review

    by Ankit Sarin, Sarah Samreen, Jennifer M. Moffett, Edmundo Inga-Zapata, Francesco Bianco, Nawar A. Alkhamesi, Jacob D. Owen, Niti Shahi, Jonathan C. DeLong, Dimitrios Stefanidis, et al.

    Background: Robotic surgical procedures continue to increase both in the United States (US) and worldwide. Several novel robotic surgical platforms are under development or undergoing regulatory approval. This review explores robotic platforms that are expected to reach US consumers within the next 2–3 years. Methods: The SAGES Robotic Platforms Working Group identified robotic surgery platforms in various stages of development and selected multi-visceral systems nearing or completing the US Food and Drug Administration (FDA) approval process. We outline key system components including architecture, unique features, development status, regulatory approval, and expected markets. Results: We identified twenty robotic platforms that met our selection criteria. Ten companies were based in North America, and ten were based in Europe or Asia. Each system is described in detail and key features are summarized in table form for easy comparison. Conclusion: The emergence of novel robotic surgical platforms represents an important evolution in the growth of minimally invasive surgery. Increased competition has the potential to bring value to surgical patients by stimulating innovation and driving down cost. The impact of these platforms remains to be determined, but the continued growth of robotic surgery seems to be all but assured.


  • Initial Experience With Single-Port Robotic Right Colectomies: Results of an Investigator-Initiated Investigational Device Exemption Study Using a Novel Single-Port Robotic Platform

    by Ankit M.D. Sarin, Katherine E. B.S. Barnes, Amy M. M.S. Shui, Yukino B.S. Nakamura, Daniel B. Hoffman, Fernanda Romero-Hernandez, Hueylan Chern

    BACKGROUND: Minimally invasive surgical techniques have been widely adopted in colorectal surgery. New technological breakthroughs have led to even less invasive alternatives like single-port surgery, but this has been hindered by technical challenges such as the collision of robotic arms within a limited space. The Intuitive da Vinci Single-Port robotic platform is a novel system that overcomes some of these challenges. IMPACT OF INNOVATION: This study aimed to assess the safety and feasibility of the Intuitive da Vinci Single-Port robotic platform in right segmental colectomies among adult patients. These findings may set the stage for more widespread use of single-port robotic surgery. TECHNOLOGY, MATERIALS, AND METHODS: The Intuitive da Vinci Single-Port robot is a system designed specifically for single-port robotic surgery. This platform enables flexible port location and efficient internal and external range of motion using a single C-shaped arm. In the present study, right colectomies were performed in adult patients using this platform between May 2022 and November 2022, and they were compared to right colectomies in adult patients performed using the standard multiport platform between January 2019 and December 2022. The main outcome measure was safety and quality event rates. PRELIMINARY RESULTS: Of 30 patients, 16.7% of patients (n = 5) underwent single-port robotic right colectomy and 83.3% (n = 25) underwent multiport right colectomy. In the single-port group, 40% of patients (n = 2) developed a safety/quality event (postoperative portal vein thrombosis and excessive postoperative pain). In the multiport group, 32% of patients (n = 8) developed 1 safety/quality event and 8% (n = 2) had more than 1 event. CONCLUSIONS AND FUTURE DIRECTIONS: This preliminary study, one of the first Food and Drug Administration–approved, investigator-initiated uses of this platform in colorectal surgeries, shows that this platform is a safe and feasible option for right colectomies. On preliminary evaluation, it appears comparable in terms of relevant safety/quality events to the multiport platform. CLINICAL TRIAL REGISTRATION: Clinicaltrials.gov NCT05321134.


  • Transanal excision of rectal lesions using the single port robotic platform: A video vignette

    by Fernanda Romero‐Hernandez, Jaeyun Jane Wang, Yukino Nakamura, Hueylan Chern, Ankit Sarin


  • Open Access

    Inadequate Lymph Node Yield: An Inadequate Indication for Adjuvant Chemotherapy in Stage II Colon Cancer

    by Alan MD Zambeli-Ljepović, Daniel Hoffman, Katherine E. Bs Barnes, Fernanda Romero-Hernandez, Amir Ashraf Ganjouei, Mohamed A. Adam, Ankit Md Sarin

    Background: Optimal therapy for stage II colon cancer remains unclear, and national guidelines recommend “consideration” of adjuvant chemotherapy (ACT) in the presence of high-risk features, including inadequate lymph node yield (LNY, P < 0.01). Inadequate LNY was independently associated with both receipt of ACT (odds ratios, 1.50; P < 0.01) and decreased overall survival [hazard ratio (HR), 1.56; P < 0.01]. ACT was independently associated with improved survival (HR, 0.67; P < 0.01); this effect size did not change based on the adequacy of LNY (interaction P = 0.41). Results were robust to re-analysis with our cohort-optimized threshold of 18 lymph nodes. Conclusions: Consistent with contemporary guidelines, patients with inadequate LNY are more likely to receive ACT. LNY adequacy is an independent prognostic factor but, in isolation, should not dictate whether patients receive ACT.


  • Open Access

    Exploring the complexity and spectrum of racial/ethnic disparities in colon cancer management

    by Anya L. Greenberg, Nathan R. Brand, Alan Zambeli-Ljepović, Katherine E. Barnes, Sy Han Chiou, Kim F. Rhoads, Mohamed A. Adam, Ankit Sarin

    Background: Colorectal cancer is a leading cause of morbidity and mortality across U.S. racial/ethnic groups. Existing studies often focus on a particular race/ethnicity or single domain within the care continuum. Granular exploration of disparities among different racial/ethnic groups across the entire colon cancer care continuum is needed. We aimed to characterize differences in colon cancer outcomes by race/ethnicity across each stage of the care continuum. Methods: We used the 2010–2017 National Cancer Database to examine differences in outcomes by race/ethnicity across six domains: clinical stage at presentation; timing of surgery; access to minimally invasive surgery; post-operative outcomes; utilization of chemotherapy; and cumulative incidence of death. Analysis was via multivariable logistic or median regression, with select demographics, hospital factors, and treatment details as covariates. Results: 326,003 patients (49.6% female, 24.0% non-White, including 12.7% Black, 6.1% Hispanic/Spanish, 1.3% East Asian, 0.9% Southeast Asian, 0.4% South Asian, 0.3% AIAE, and 0.2% NHOPI) met inclusion criteria. Relative to non-Hispanic White patients: Southeast Asian (OR 1.39, p < 0.01), Hispanic/Spanish (OR 1.11 p < 0.01), and Black (OR 1.09, p < 0.01) patients had increased odds of presenting with advanced clinical stage. Southeast Asian (OR 1.37, p < 0.01), East Asian (OR 1.27, p = 0.05), Hispanic/Spanish (OR 1.05 p = 0.02), and Black (OR 1.05, p < 0.01) patients had increased odds of advanced pathologic stage. Black patients had increased odds of experiencing a surgical delay (OR 1.33, p < 0.01); receiving non-robotic surgery (OR 1.12, p < 0.01); having post-surgical complications (OR 1.29, p < 0.01); initiating chemotherapy more than 90 days post-surgery (OR 1.24, p < 0.01); and omitting chemotherapy altogether (OR 1.12, p = 0.05). Black patients had significantly higher cumulative incidence of death at every pathologic stage relative to non-Hispanic White patients when adjusting for non-modifiable patient factors (p < 0.05, all stages), but these differences were no longer statistically significant when also adjusting for modifiable factors such as insurance status and income. Conclusions: Non-White patients disproportionately experience advanced stage at presentation. Disparities for Black patients are seen across the entire colon cancer care continuum. Targeted interventions may be appropriate for some groups; however, major system-level transformation is needed to address disparities experienced by Black patients.